The leading determinant of erectile function improvement was GLP-1 RA treatment itself, more so than changes in HbA1c, weight, or other metabolic parameters
A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction
For women in Buckeye struggling with PCOS (Polycystic Ovary Syndrome), weight loss is frequently hindered by severe insulin resistance
Systemic hormone effects: GLP-1 receptors exist throughout the body, including in the heart, blood vessels, kidneys, and liver
They are currently licensed only for type 2 diabetes and obesity, and their use in Parkinson's is considered experimental and investigational within clinical trials
They all have excellent and different functions and are deeply loved by people all of the world